Background Postpartum haemorrhage (PPH) is a common and potentially life‐threatening
complication of labour. Several options for preventing PPH are available, but further …

Perioperative blood loss is a significant concern for patients undergoing total joint
arthroplasty. A growing body of evidence has shown tranexamic acid (TXA) to be effective in …

Background: Abundant literature regarding the use of intravenous tranexamic acid (TXA) in
primary total knee replacement is available. Randomized controlled trials have confirmed …

Background: Highly porous surfaces promoting biologic fixation have renewed interest in
cementless total knee arthroplasty (TKA), but the potential for failed biologic fixation remains …

Background Tranexamic acid (TXA) is effective in reducing blood loss in total joint
arthroplasty (TJA), but concerns still remain regarding the drug's safety. The purpose of this …

Tranexamic acid (TNA) reduces postoperative blood loss in general and obstetrical surgery
but there is limited orthopaedic literature regarding its use in the topical setting. To study the …

The ideal method of providing tranexamic acid (TXA) for decreasing hemoglobin drop after
TKA is still controversial. In this clinical trial, 200 patients were randomly allocated to four …

Background: Tranexamic acid (TXA) reduces bleeding and the need for transfusion after
total knee arthroplasty. Most literature has focused on intravenous (IV) administration of TXA …

The number of arthroplasties being performed increases each year. Patients undergoing an
arthroplasty are at risk of venous thromboembolism (VTE) and appropriate prophylaxis has …

Background Tranexamic acid (TXA) is well-established as a versatile oral, intramuscular,
and intravenous (IV) antifibrinolytic agent. However, the efficacy of IV TXA in reducing …